Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Hc Meissner"'
Autor:
[No Value] Groothuis, Gr Siber, Wj Rodriguez, Vg Hemming, Ga Prince, Julita O. Arrobio, Mj Levin, Fulton, Ce Long, Rc Welliver, Hc Meissner, M Vanraden, Cb Hall, Da Tristram, Eaf Simoes
Publikováno v:
New England Journal of Medicine. 329:1524-1530
Background Infants with cardiac disease or prematurity are at risk for severe illness caused by respiratory syncytial virus. Immune globulin with a high titer of antibodies against respiratory syncytial virus may offer infants and young children at r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ba65f5f1abfc5d4bc5b15f1328201ea
https://doi.org/10.1056/nejm199311183292102
https://doi.org/10.1056/nejm199311183292102
Autor:
Wolfe DN; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, Department of Health and Human Services, Washington, DC, USA., Arangies E; Rho, Incorporated, Federal Research Operations, Durham, NC, USA., David GL; Rho, Incorporated, Federal Research Operations, Durham, NC, USA., Armstrong B; Rho, Incorporated, Federal Research Operations, Durham, NC, USA., Scocca TZ; Rho, Incorporated, Federal Research Operations, Durham, NC, USA., Fedler J; Rho, Incorporated, Federal Research Operations, Durham, NC, USA., Natarajan R; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, Department of Health and Human Services, Washington, DC, USA., Zhou J; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, Department of Health and Human Services, Washington, DC, USA., Jayashankar L; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, Department of Health and Human Services, Washington, DC, USA., Donis R; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, Department of Health and Human Services, Washington, DC, USA., Nesin M; Tunnell Government Services, Berwyn, Pennsylvania, USA., Meissner HC; Tunnell Government Services, Berwyn, Pennsylvania, USA.; Department of Medicine and Pediatrics, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA., Lemiale L; Tunnell Government Services, Berwyn, Pennsylvania, USA., Kovacs GR; Tunnell Government Services, Berwyn, Pennsylvania, USA., Rele S; Shabas Solutions, Fairfax, Virginia, USA., Mason R; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, Department of Health and Human Services, Washington, DC, USA., Cao H; Tunnell Government Services, Berwyn, Pennsylvania, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Oct 15; Vol. 79 (4), pp. 928-935.
Autor:
Meissner HC; From the Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, Department of Health and Human Services, Washington, DC (H.C.M., B.G.K., D.N.W.); Tunnell Government Services, Berwyn, PA (H.C.M.); and the Dartmouth International Vaccine Initiative at the Geisel School of Medicine at Dartmouth, Hanover, NH (H.C.M.)., Kapogiannis BG; From the Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, Department of Health and Human Services, Washington, DC (H.C.M., B.G.K., D.N.W.); Tunnell Government Services, Berwyn, PA (H.C.M.); and the Dartmouth International Vaccine Initiative at the Geisel School of Medicine at Dartmouth, Hanover, NH (H.C.M.)., Wolfe DN; From the Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, Department of Health and Human Services, Washington, DC (H.C.M., B.G.K., D.N.W.); Tunnell Government Services, Berwyn, PA (H.C.M.); and the Dartmouth International Vaccine Initiative at the Geisel School of Medicine at Dartmouth, Hanover, NH (H.C.M.).
Publikováno v:
The New England journal of medicine [N Engl J Med] 2024 Jul 18; Vol. 391 (3), pp. 196-199. Date of Electronic Publication: 2024 Jul 13.
Autor:
Meissner HC; Departments of Pediatrics & Medicine, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, New Hampshire; and Tunnell Government Services in support of Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, District of Columbia.
Publikováno v:
Pediatrics [Pediatrics] 2023 Nov 01; Vol. 152 (5).
Autor:
Meissner HC; From the Department of Pediatrics, Tufts Children's Hospital, Tufts Medical Center, Boston.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2022 Apr 28; Vol. 386 (17), pp. 1638-1645.
Autor:
Meissner HC; Tufts Children's Hospital, Tufts University School of Medicine, Boston, Massachusetts., Steere AC; Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Pediatrics [Pediatrics] 2022 Mar 01; Vol. 149 (3).
Autor:
Choi Y; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, 1225 Center Drive, Gainesville, FL, 32611, USA., Meissner HC; Tufts Children's Hospital, Tufts Medical Center, Boston, USA.; Tufts University School of Medicine, Boston, USA., Hampp C; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, USA., Park H; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, 1225 Center Drive, Gainesville, FL, 32611, USA.; Center for Drug Evaluation and Safety (CoDES), University of Florida, 1225 Center Drive, Gainesville, FL, 32611, USA., Winterstein AG; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, 1225 Center Drive, Gainesville, FL, 32611, USA. Almut@ufl.edu.; Center for Drug Evaluation and Safety (CoDES), University of Florida, 1225 Center Drive, Gainesville, FL, 32611, USA. Almut@ufl.edu.; Department of Epidemiology, College of Public Health and Health Professionals and College of Medicine, University of Florida, 1225 Center Drive, Gainesville, FL, 32611, USA. Almut@ufl.edu.
Publikováno v:
European journal of pediatrics [Eur J Pediatr] 2022 Feb; Vol. 181 (2), pp. 841-845. Date of Electronic Publication: 2021 Aug 07.
Autor:
Hale JE; New England Newborn Screening Program, Commonwealth Medicine, University of Massachusetts Medical School, Worcester, Mass., Platt CD; Division of Immunology, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass., Bonilla FA; Division of Immunology, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass; Northeast Allergy, Asthma & Immunology, Leominster, Mass., Hay BN; Department of Pediatrics, University of Massachusetts Medical School, Worcester, Mass., Sullivan JL; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Mass., Johnston AM; Harvard Medical School, Boston, Mass; Division of Infectious Disease, Boston Children's Hospital, Boston, Mass., Pasternack MS; Harvard Medical School, Boston, Mass; Pediatric Infectious Disease Unit, MassGeneral Hospital for Children, Boston, Mass., Hesterberg PE; Division of Allergy and Immunology, MassGeneral Hospital for Children, Boston, Mass., Meissner HC; Department of Pediatrics, Tufts Children's Hospital, Tufts University School of Medicine, Boston, Mass., Cooper ER; Division of Pediatric Infectious Diseases, Boston Medical Center, Boston University School of Medicine, Boston, Mass., Barmettler S; Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Boston, Mass., Farmer JR; Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Boston, Mass., Fisher D; Division of Pediatric Infectious Diseases, Baystate Children's Hospital, University of Massachusetts Medical School-Baystate, Springfield, Mass., Walter JE; Division of Allergy and Immunology, MassGeneral Hospital for Children, Boston, Mass; Division of Allergy & Immunology, Department of Pediatrics, University of South Florida at Johns Hopkins All Children's Hospital, St. Petersburg, Fla., Yang NJ; Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Boston, Mass., Sahai I; New England Newborn Screening Program, Commonwealth Medicine, University of Massachusetts Medical School, Worcester, Mass; Department of Pediatrics, University of Massachusetts Medical School, Worcester, Mass., Eaton RB; New England Newborn Screening Program, Commonwealth Medicine, University of Massachusetts Medical School, Worcester, Mass; Department of Pediatrics, University of Massachusetts Medical School, Worcester, Mass., DeMaria A; Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Boston, Mass., Notarangelo LD; Laboratory of Clinical Immunology & Microbiology, National Institute of Allergy and Infectious Diseases, Bethesda, Md., Pai SY; Harvard Medical School, Boston, Mass; Division of Hematology-Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Mass; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Mass. Electronic address: sung-yun.pai@nih.gov., Comeau AM; New England Newborn Screening Program, Commonwealth Medicine, University of Massachusetts Medical School, Worcester, Mass; Department of Pediatrics, University of Massachusetts Medical School, Worcester, Mass. Electronic address: anne.comeau@umassmed.edu.
Publikováno v:
The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2021 May; Vol. 9 (5), pp. 2060-2067.e2. Date of Electronic Publication: 2021 Feb 16.
Autor:
Choi Y; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA., Meissner HC; Department of Pediatrics, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA., Hampp C; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA.; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Park H; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA.; Center for Drug Evaluation and Safety, University of Florida, Gainesville, Florida, USA., Brumback B; Center for Drug Evaluation and Safety, University of Florida, Gainesville, Florida, USA.; Department of Biostatistics, College of Public Health and Health Professionals and College of Medicine, University of Florida, Gainesville, Florida, USA., Winterstein AG; Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA.; Center for Drug Evaluation and Safety, University of Florida, Gainesville, Florida, USA.; Department of Epidemiology, College of Public Health and Health Professionals and College of Medicine, University of Florida, Gainesville, Florida, USA.
Publikováno v:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2021 Apr 03; Vol. 10 (3), pp. 317-325.
Autor:
Meissner HC; Tufts Children's Hospital, Tufts University School of Medicine, Boston, Massachusetts.
Publikováno v:
JAMA [JAMA] 2021 Feb 23; Vol. 325 (8), pp. 721-722.